May 3
|
Alnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y
|
May 3
|
Why selling to Novartis made sense for Mariana
|
May 2
|
Top Midday Stories: Novo Nordisk, Linde Shares Fall Post-Earnings; Peloton Shares Plummet After Announcing Job Cuts, CEO Change; Exxon-Pioneer Deal Gets FTC Approval With One Caveat
|
May 2
|
Novartis to buy Mariana Oncology in radiopharmaceutical expansion
|
May 2
|
UPDATE 2-Novartis to buy radiology drug specialist Mariana for $1 billion
|
May 2
|
The top pharmaceutical companies by R&D expenditure
|
May 1
|
CVS stock plunges after earnings numbers one analyst 'did not even believe'
|
May 1
|
Novartis Is Tracking Well Above the Industry
|
Apr 30
|
Update: FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications
|
Apr 30
|
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
Apr 29
|
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
|
Mar 31
|
25 Countries with Highest Malaria Death Rates
|
Mar 30
|
11 Oversold Blue Chip Stocks to Buy Right Now
|
Mar 29
|
15 Biggest Swiss Companies
|
Mar 28
|
Investors Heavily Search Novartis AG (NVS): Here is What You Need to Know
|
Mar 27
|
Novartis (NVS) Increases Yet Falls Behind Market: What Investors Need to Know
|
Mar 27
|
Mesoblast (MESO) to File Pediatric GVHD Drug BLA, Stock Up
|
Mar 25
|
Novartis (NVS) Declines More Than Market: Some Information for Investors
|
Mar 25
|
30 Countries with Highest Proportion of Older Adults
|
Feb 4
|
3 Fabulous Dividend Stocks to Buy in February
|